Annual Cash & Cash Equivalents
$24.95 M
-$95.28 M-79.25%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual cash & cash equivalents is currently $24.95 million, with the most recent change of -$95.28 million (-79.25%) on 31 December 2023. During the last 3 years, it has fallen by -$52.12 million (-67.63%). TNXP annual cash & cash equivalents is now -86.04% below its all-time high of $178.66 million, reached on 31 December 2021.TNXP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$28.23 M
+$24.08 M+579.33%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly cash and cash equivalents is currently $28.23 million, with the most recent change of +$24.08 million (+579.33%) on 30 September 2024. Over the past year, it has increased by +$21.32 million (+308.35%). TNXP quarterly cash and cash equivalents is now -84.57% below its all-time high of $182.97 million, reached on 30 September 2021.TNXP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.3% | +308.4% |
| 3 y3 years | -67.6% | -84.6% |
| 5 y5 years | -0.3% | +181.7% |
TNXP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -86.0% | at low | -84.6% | +579.3% |
| 5 y | 5 years | -86.0% | +121.8% | -84.6% | +579.3% |
| alltime | all time | -86.0% | >+9999.0% | -84.6% | >+9999.0% |
Tonix Pharmaceuticals Holding Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.23 M(+579.3%) |
| June 2024 | - | $4.16 M(-41.0%) |
| Mar 2024 | - | $7.05 M(-71.7%) |
| Dec 2023 | $24.95 M(-79.2%) | $24.95 M(+260.8%) |
| Sept 2023 | - | $6.91 M(-73.0%) |
| June 2023 | - | $25.62 M(-64.4%) |
| Mar 2023 | - | $71.97 M(-40.1%) |
| Dec 2022 | $120.23 M(-32.7%) | $120.23 M(-14.1%) |
| Sept 2022 | - | $139.98 M(-3.8%) |
| June 2022 | - | $145.48 M(+3.6%) |
| Mar 2022 | - | $140.44 M(-21.4%) |
| Dec 2021 | $178.66 M(+131.8%) | $178.66 M(-2.4%) |
| Sept 2021 | - | $182.97 M(+10.4%) |
| June 2021 | - | $165.72 M(+0.9%) |
| Mar 2021 | - | $164.21 M(+113.1%) |
| Dec 2020 | $77.07 M(+585.1%) | $77.07 M(+38.5%) |
| Sept 2020 | - | $55.66 M(+1.2%) |
| June 2020 | - | $55.02 M(+79.4%) |
| Mar 2020 | - | $30.66 M(+172.6%) |
| Dec 2019 | $11.25 M(-55.1%) | $11.25 M(+12.2%) |
| Sept 2019 | - | $10.02 M(-17.5%) |
| June 2019 | - | $12.15 M(-26.1%) |
| Mar 2019 | - | $16.45 M(-34.3%) |
| Dec 2018 | $25.03 M(-1.8%) | $25.03 M(+70.6%) |
| Sept 2018 | - | $14.67 M(-12.0%) |
| June 2018 | - | $16.68 M(-13.4%) |
| Mar 2018 | - | $19.25 M(-24.5%) |
| Dec 2017 | $25.50 M(+34.6%) | $25.50 M(-13.0%) |
| Sept 2017 | - | $29.31 M(-14.7%) |
| June 2017 | - | $34.35 M(+72.3%) |
| Mar 2017 | - | $19.94 M(+5.3%) |
| Dec 2016 | $18.94 M | $18.94 M(+21.1%) |
| Sept 2016 | - | $15.64 M(+4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $14.94 M(+77.3%) |
| Mar 2016 | - | $8.43 M(-56.1%) |
| Dec 2015 | $19.18 M(-49.8%) | $19.18 M(-41.9%) |
| Sept 2015 | - | $33.01 M(-32.3%) |
| June 2015 | - | $48.74 M(-16.2%) |
| Mar 2015 | - | $58.18 M(+52.4%) |
| Dec 2014 | $38.18 M(+365.5%) | $38.18 M(-17.4%) |
| Sept 2014 | - | $46.23 M(+5.4%) |
| June 2014 | - | $43.87 M(-11.5%) |
| Mar 2014 | - | $49.55 M(+504.1%) |
| Dec 2013 | $8.20 M(+359.5%) | $8.20 M(+10.5%) |
| Sept 2013 | - | $7.42 M(>+9900.0%) |
| June 2013 | - | $68.00 K(-84.0%) |
| Mar 2013 | - | $423.70 K(-76.3%) |
| Dec 2012 | $1.78 M(+4243.1%) | $1.78 M(+4900.0%) |
| Sept 2012 | - | $35.70 K(-97.3%) |
| June 2012 | - | $1.34 M(-46.5%) |
| Mar 2012 | - | $2.50 M(+5986.1%) |
| Dec 2011 | $41.10 K(-37.2%) | $41.10 K(>+9900.0%) |
| Sept 2011 | - | $200.00(-71.4%) |
| June 2011 | - | $700.00(-50.0%) |
| Mar 2011 | - | $1400.00(-97.9%) |
| Dec 2010 | $65.40 K(+419.0%) | $65.40 K(+1495.1%) |
| Sept 2010 | - | $4100.00(0.0%) |
| June 2010 | - | $4100.00(-32.8%) |
| Mar 2010 | - | $6100.00(-51.6%) |
| Dec 2009 | $12.60 K(-68.9%) | $12.60 K(-15.4%) |
| Sept 2009 | - | $14.90 K(-14.9%) |
| June 2009 | - | $17.50 K(-44.3%) |
| Mar 2009 | - | $31.40 K(-22.5%) |
| Dec 2008 | $40.50 K | $40.50 K(+5.5%) |
| Sept 2008 | - | $38.40 K(+80.3%) |
| June 2008 | - | $21.30 K(+326.0%) |
| Mar 2008 | - | $5000.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual cash & cash equivalents year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly cash and cash equivalents year-on-year change?
What is Tonix Pharmaceuticals Holding annual cash & cash equivalents?
The current annual cash & cash equivalents of TNXP is $24.95 M
What is the all time high annual cash & cash equivalents for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual cash & cash equivalents is $178.66 M
What is Tonix Pharmaceuticals Holding annual cash & cash equivalents year-on-year change?
Over the past year, TNXP annual cash & cash equivalents has changed by -$95.28 M (-79.25%)
What is Tonix Pharmaceuticals Holding quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TNXP is $28.23 M
What is the all time high quarterly cash and cash equivalents for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly cash and cash equivalents is $182.97 M
What is Tonix Pharmaceuticals Holding quarterly cash and cash equivalents year-on-year change?
Over the past year, TNXP quarterly cash and cash equivalents has changed by +$21.32 M (+308.35%)